These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19652895)
21. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors. Wallin R; Wajih N; Hutson SM Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197 [TBL] [Abstract][Full Text] [Related]
22. Recent findings in understanding the biological function of vitamin K. Uotila L; Suttie JW Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084 [TBL] [Abstract][Full Text] [Related]
24. Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population. Au NT; Reyes M; Boyer BB; Hopkins SE; Black J; O'Brien D; Fohner AE; Yracheta J; Thornton T; Austin MA; Burke W; Thummel KE; Rettie AE PLoS One; 2017; 12(4):e0173616. PubMed ID: 28376131 [TBL] [Abstract][Full Text] [Related]
25. VKORC1 and the vitamin K cycle. Garcia AA; Reitsma PH Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188 [TBL] [Abstract][Full Text] [Related]
26. Congenital deficiency of vitamin K dependent coagulation factors--its rarity and need for an international registry. Ghosh K; Shetty S; Mohanty D Thromb Haemost; 2001 Oct; 86(4):1131. PubMed ID: 11686345 [No Abstract] [Full Text] [Related]
27. More on: endoplasmic reticulum loop VKORC1 substitutions cause warfarin resistance but do not diminish gamma-carboxylation of the vitamin K-dependent coagulation factors. Harrington DJ; Siddiq S; Allford SL; Shearer MJ; Mumford AD J Thromb Haemost; 2011 May; 9(5):1093-5. PubMed ID: 21362126 [No Abstract] [Full Text] [Related]
28. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X. Sun YM; Jin DY; Camire RM; Stafford DW Blood; 2005 Dec; 106(12):3811-5. PubMed ID: 16081695 [TBL] [Abstract][Full Text] [Related]
29. Structural and functional insights into enzymes of the vitamin K cycle. Tie JK; Stafford DW J Thromb Haemost; 2016 Feb; 14(2):236-47. PubMed ID: 26663892 [TBL] [Abstract][Full Text] [Related]
30. Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study. Sconce EA; Avery PJ; Wynne HA; Kamali F J Thromb Haemost; 2008 Jul; 6(7):1226-8. PubMed ID: 18466315 [No Abstract] [Full Text] [Related]
31. Building individualized medicine: prevention of adverse reactions to warfarin therapy. Krynetskiy E; McDonnell P J Pharmacol Exp Ther; 2007 Aug; 322(2):427-34. PubMed ID: 17496169 [TBL] [Abstract][Full Text] [Related]
33. VKCFD2 - from clinical phenotype to molecular mechanism. Czogalla KJ; Watzka M; Oldenburg J Hamostaseologie; 2016 Nov; 36(Suppl. 2):S13-S20. PubMed ID: 27824210 [TBL] [Abstract][Full Text] [Related]
34. GGCX-Associated Phenotypes: An Overview in Search of Genotype-Phenotype Correlations. De Vilder EY; Debacker J; Vanakker OM Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28125048 [TBL] [Abstract][Full Text] [Related]
35. The association between dietary vitamin K intake and serum undercarboxylated osteocalcin is modulated by vitamin K epoxide reductase genotype. Nimptsch K; Nieters A; Hailer S; Wolfram G; Linseisen J Br J Nutr; 2009 Jun; 101(12):1812-20. PubMed ID: 19025725 [TBL] [Abstract][Full Text] [Related]
36. Congenital combined deficiencies of all vitamin K-dependent coagulation factors. Mousallem M; Spronk HM; Sacy R; Hakime N; Soute BA Thromb Haemost; 2001 Nov; 86(5):1334-6. PubMed ID: 11816728 [No Abstract] [Full Text] [Related]
37. GGCX-related congenital combined vitamin K-dependent clotting factors deficiency-1: Description of a fetus with chondrodysplasia punctata. Mathonnet A; Cunat S; Allias F; Caillot S; Thonnon C; Till M; Attié-Bitach T; Touraine R; Meunier S; Cartellier C; Rossi M; Attia J; Putoux A Am J Med Genet A; 2022 Jan; 188(1):314-318. PubMed ID: 34558179 [TBL] [Abstract][Full Text] [Related]
38. Vitamin K epoxide reductase: homology, active site and catalytic mechanism. Goodstadt L; Ponting CP Trends Biochem Sci; 2004 Jun; 29(6):289-92. PubMed ID: 15276181 [TBL] [Abstract][Full Text] [Related]
39. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle. Wajih N; Hutson SM; Owen J; Wallin R J Biol Chem; 2005 Sep; 280(36):31603-7. PubMed ID: 16030016 [TBL] [Abstract][Full Text] [Related]